The Seattle Coronavirus Assessment Network announced on its website May 14 that the FDA has ordered it to pause testing after the agency clarified requirements for at-home COVID-19 testing. The program had been sending testing kits to the local residents’ homes and found dozens of cases that had been previously undiagnosed.
“The FDA has not raised any concerns regarding the safety and accuracy of SCAN’s test, but we have been asked to pause testing until we receive that additional authorization,” SCAN wrote on its website.
The pause highlights the disconnect between federal officials proposing guidelines and leaving much of diagnostic testing efforts to localities.
More articles on pharmacy:
Sanofi CEO blasted for saying US should get coronavirus vaccine first
Moderna releases positive data on early COVID-19 vaccine trial
American Pharmacists Association releases 2020 board election results
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.